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Abstract
The effect of intracarotid infusion of etoposide on the permeability of the blood-brain bar-
rier (BBB) and brain-tumor barrier (BTB) was investigated using a model of rats injected with
C6 glioma cells. Fifty four glioma-bearing rats were divided into 3 groups and treated with 0,
3, or 15 mg/kg of etoposide infused into the internal carotid artery. BBB or BTB permeability
was evaluated qualitatively by the leakage of Evans blue (6 animals in each group) or quantita-
tively by the diffusion of carboplatin [cis-diammine (1,1-cyclobutane-dicarboxylato) platinum(II);
CBDCA] (12 animals in each group) into the normal brain or the tumor tissue. BBB and BTB dis-
ruption augmented significantly in proportion to the dose of etoposide. The degree of disruption
of BTB was greater than that of BBB, but the rate of disruption of BBB in proportion to increasing
the dose of etoposide was higher than that in the BTB. Histopathologically, no obvious changes
were observed in the animals of either the control group or the 3 mg/kg group but degenerative
changes in the neurons of the hippocampus of the infused hemisphere were seen in the 15 mg/kg
group. This change is thought to be caused by apoptosis because of the positive reaction with TdT-
mediated dUTP-biotin nick-end labeling (TUNEL) method. Our results suggest that intracarotid
infusion of etoposide can increase drug delivery of concurrent antitumor agents into tumor tissue,
but cerebral parenchymal cell damage is expected with a higher dosage of etoposide. Therefore,
the dosage of etoposide for intracarotid infusion should be lower than 15 mg/kg in order to reduce
neurotoxicity of both etoposide and concurrent anticancer drugs.
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